Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Pancreas Cancer
89%
Neoplasm
85%
Mucin 4
59%
Pancreas Adenocarcinoma
58%
Mucin
50%
Pharmacokinetics
36%
Epidermal Growth Factor Receptor
29%
Mouse
25%
Carcinogenesis
24%
Mouse Model
23%
Biodistribution
23%
Biological Marker
22%
Ovary Cancer
22%
Tumor Microenvironment
20%
Single Chain Fragment Variable Antibody
19%
Solid Malignant Neoplasm
19%
Disease
19%
Afatinib
19%
Monoclonal Antibody
18%
Radioisotope
16%
Inflammation
15%
Lung Cancer
13%
Immunotherapy
13%
Radioactive Iodine
13%
Monoclonal Antibody CC49
13%
Head and Neck Squamous Cell Carcinoma
13%
Lutetium 177
13%
Glioblastoma
13%
Pancreas Tumor
13%
microRNA
10%
Metastasis
10%
Immunosuppressive Agent
10%
Clinical Trial
10%
Liver Metastasis
10%
Iodine-131
9%
Epitope
9%
Ovary Carcinoma
8%
Tumor Antigen
8%
Therapy Resistance
8%
Mucin 1
8%
Divalent
8%
Chemotherapy
8%
Chelating Agent
7%
Uvomorulin
7%
Small Cell Lung Cancer
7%
Temozolomide
7%
Breast Cancer
7%
Cachexia
7%
Chimeric Antibody
6%
Medicine and Dentistry
Pancreas Cancer
96%
Pancreas Adenocarcinoma
75%
Neoplasm
57%
Malignant Neoplasm
52%
Mucin 4
49%
Mucin
41%
Metastatic Carcinoma
32%
Disease
26%
Exosome
23%
Biological Marker
21%
Epidermal Growth Factor Receptor
20%
Diagnosis
19%
Radiosensitivity
16%
Ovarian Cancer
15%
Small Cell Lung Cancer
14%
Cancer Cell
14%
Immunotherapy
13%
Neutrophil Gelatinase Associated Lipocalin
13%
Surface Enhanced Raman Spectroscopy
13%
Head and Neck Squamous Cell Carcinoma
13%
Afatinib
13%
Cystic Pancreatic Lesion
13%
Cancer
12%
Fibroblast
12%
Cell Line
12%
Tumor Antigen
11%
Clinical Trial
11%
Cancer Therapy
10%
Liver Metastasis
10%
Early Diagnosis
10%
Upregulation
10%
Mucin 1
9%
Mucin 5AC
9%
Cancer Growth
9%
Geranyltransferase
9%
Immunosuppressive Drug
9%
Desmoplasia
8%
CA-125
8%
Krukenberg Tumor
8%
Radiosensitization
8%
Carboxy Terminal Sequence
8%
Radiation Therapy
8%
Immune Checkpoint Blockade
8%
Cell Migration
8%
Targeted Therapy
8%
Overall Survival
7%
Pancreatic Ductal Adenocarcinoma
7%
Lung Cancer
7%
Therapy Resistance
7%
Immunosuppressive Treatment
7%
Keyphrases
MUC16
32%
Pancreatic Ductal Adenocarcinoma
32%
Pancreatic Cancer
32%
MUC4
28%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
19%
Metastasis
16%
Mucin
16%
Pancreatic Cancer Treatment
15%
Tumorigenesis
13%
Macrophage Inhibitory cytokine-1 (MIC-1)
13%
MUC4 mucin
13%
Carbohydrate Antigen 19-9 (CA19-9)
11%
Early Diagnosis
9%
Radiohalogens
9%
Cancer Resistance
9%
Therapeutic Target
8%
Ovarian Cancer
8%
Pancreas
7%
Chronic Pancreatitis
7%
Recombinant
7%
Liver Metastasis
7%
Stromal Heterogeneity
7%
Tumor
7%
Cancer-related
7%
Specific Monoclonal Antibodies
7%
Pancreatic Tumor
7%
Pancreatic Adenocarcinoma
7%
Malignancy
6%
Antibody Labeling
6%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
6%
Targeting Cancer Stem Cells
6%
Triple-negative Breast Cancer Cells
6%
Desmoplasia
6%
Cancer Marker
6%
Serum miRNAs
6%
Gold Nanoprobes
6%
Biosensing Technology
6%
Pre-metastatic Niche Formation
6%
Radioiodine
6%
Radiometals
6%
Pancreatic Cancer Biomarkers
6%
Cancer Antigen
6%
Pathological Function
6%
Benign Disease
6%
Cancer Therapy
6%
Immune Regulation
6%
Model Potential
6%
Tumor Microenvironment Factors
6%
Clinical Potential
6%
Endothelin Axis
6%